To develop and deploy a syphilis vaccine that will be effective globally, it is important to understand local risk factors associated with acquisition and transmission of the disease, barriers to timely diagnosis and care, typical and atypical clinical presentations, and, most importantly, the genomic diversity of circulating TPA strains. The gene discussed is PLAT; the disease is syphilis.